Both the neutralizing anti-CD40 monoclonal antibodies and the non-antibody scaffold protein VIB4920 (a human CD40L inhibitor) have been shown to inhibit CIA development by reversing arthritis and blocking immune cells from accessing synovial tissue [169,170]. Here, CD40 is linked to arthritic joint disease.